Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are currently being treated with Bosulif, or who are about to start treatment with Bosulif, as part of their normal medical care (including those who started Bosulif within the past year before signing consent)
- People who have signed and dated a consent form, confirming they have been told about all relevant aspects of the study (a legal representative may sign on behalf of the patient if needed)
Who may not be able to join:
- People for whom Bosulif is listed as unsuitable or unsafe according to the official product information in their country
- People who do not agree to allow Pfizer and its partner companies to use their personal information for the study (or whose legal representative does not agree on their behalf)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of AEs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.